Try it
Dermatology · Drug reactions: nevirapine rash
Sample itemA woman with HIV is to start a nevirapine-based regimen. Which approach reduces the risk of severe rash and hepatotoxicity?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Lead-in dosing at half the dose for the first 14 days
Nevirapine causes rash, including SJS/TEN, and hepatotoxicity, mostly in the first 18 weeks and particularly in women with higher CD4 counts. A 14-day lead-in at half the dose reduces the risk. Prophylactic corticosteroids do not help and may increase rash.
Option by option
A. Lead-in dosing at half the dose for the first 14 days (correct)
Correct. A 14-day lead-in at half dose allows induction of metabolism and reduces rash.
B. Prophylactic prednisolone during the first month
Prophylactic prednisolone has been shown not to prevent nevirapine rash and may increase it.
C. Starting the full dose at bedtime on an empty stomach
Timing of the dose and food do not alter the risk of hypersensitivity.
D. Co-administration of cotrimoxazole for the first 6 weeks
Cotrimoxazole is a sulfonamide that can itself cause rash and does not protect against nevirapine reactions.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Dermatology questions
- Blistering disordersA patient has flaccid blisters that rupture easily and a positive Nikolsky sign. Which c…
- LeprosyIn which type of leprosy is the lepromin test strongly positive?
- Pigmentary disordersA man has well-demarcated chalk-white macules on his hands and around his mouth. A skin…
- Drug reactionsWhich of the following drugs is a well-recognised trigger of Stevens–Johnson syndrome an…